Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenon Medical (TNON) EBITDA (2021 - 2025)

Tenon Medical has reported EBITDA over the past 5 years, most recently at -$2.8 million for Q4 2025.

  • Quarterly results put EBITDA at -$2.8 million for Q4 2025, up 8.26% from a year ago — trailing twelve months through Dec 2025 was -$12.6 million (up 7.86% YoY), and the annual figure for FY2025 was -$12.6 million, up 7.86%.
  • EBITDA for Q4 2025 was -$2.8 million at Tenon Medical, up from -$3.3 million in the prior quarter.
  • Over the last five years, EBITDA for TNON hit a ceiling of -$200000.0 in Q1 2021 and a floor of -$7.8 million in Q4 2022.
  • Median EBITDA over the past 5 years was -$3.2 million (2022), compared with a mean of -$3.4 million.
  • Biggest five-year swings in EBITDA: crashed 1076.5% in 2022 and later surged 60.72% in 2023.
  • Tenon Medical's EBITDA stood at -$2.9 million in 2021, then tumbled by 172.59% to -$7.8 million in 2022, then surged by 60.72% to -$3.1 million in 2023, then fell by 0.29% to -$3.1 million in 2024, then increased by 8.26% to -$2.8 million in 2025.
  • The last three reported values for EBITDA were -$2.8 million (Q4 2025), -$3.3 million (Q3 2025), and -$2.8 million (Q2 2025) per Business Quant data.